The aim is to establish the maximal tolerated dose of AZD3355 for the selection of doses in
the up-coming studies. This will be done by comparing single and repeated doses of AZD3355 to
placebo ("inactive substance"). Safety and tolerability variables will be closely monitored
throughout the study.